Dr Aaron Rosenberg, MD | |
1516 W Mequon Rd Ste 103, Mequon, WI 53092-3264 | |
(262) 242-0700 | |
(855) 457-1293 |
Full Name | Dr Aaron Rosenberg |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1516 W Mequon Rd Ste 103, Mequon, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306237417 | NPI | - | NPPES |
63589 | Other | WI | STATE LICENSE |
100052457 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 63589-20 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Aaron Rosenberg, MD Po Box 639, Thiensville, WI 53092-0639 Ph: (262) 242-0700 | Dr Aaron Rosenberg, MD 1516 W Mequon Rd Ste 103, Mequon, WI 53092-3264 Ph: (262) 242-0700 |
News Archive
New research shows that more than half of women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have fewer children than desired. While patient choice has some influence on the smaller family size, findings published today in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), suggest that higher rates of infertility and miscarriage may also impact the number of offspring born to women with these chronic conditions.
The incidence of a potentially life-threatening complication of diabetes, diabetic ketoacidosis, in youth in Colorado at the time of diagnosis of type 1 diabetes increased by 55 percent between 1998 and 2012, suggesting a growing number of youth may experience delays in diagnosis and treatment, according to a study in the April 21 issue of JAMA, a theme issue on child health.
Drinking 12 ounces of sugary drinks more than once per day is linked to lower levels of high-density lipoprotein cholesterol (HDL-C), ("good" cholesterol), and higher levels of triglycerides, in middle-aged and older adults, both of which have been shown to increase risk of cardiovascular disease.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Park Systems, a leading manufacturer of atomic force microscopy (AFM) and nanoscale metrology products, proudly introduces Park NX-Bio, a powerful 3-in-1 bio-research tool that uniquely combines scanning ion conductance microscopy (SICM) with AFM and an inverted optical microscope (IOM) on the same platform.
› Verified 3 days ago